A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO

被引：1
|
作者：
Arocho, R. [1 ]
Northridge, K. [2 ]
Rivera Hurtado, R. [3 ]
Garcia Chavez, J. [4 ]
机构：
[1] Amgen Inc, Barcelona, Spain
[2] Outcomes Insights Inc, Westlake Village, CA USA
[3] Amgen Mexico, Mexico City, DF, Mexico
[4] Mexican Inst Social Secur IMSS, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.350
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A62 / A62
页数：1
相关论文
共 50 条
  • [31] ROMIPLOSTIM: EFFICACY AND SAFETY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP). SINGLE CENTRE EXPERIENCE
    Zotova, I.
    Abdulkadyrov, K.
    [J]. HAEMATOLOGICA, 2014, 99 : 208 - 208
  • [32] Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment
    Semple, John W.
    Schifferli, Alexandra
    Cooper, Nichola
    Saad, Hossam
    Mytych, Daniel T.
    Chea, Lynette S.
    Newland, Adrian
    [J]. BLOOD REVIEWS, 2024, 67
  • [33] EFFICACY AND SAFETY OF ROMIPLOSTIM VERSUS MEDICAL STANDARD OF CARE AS CHRONIC THERAPY FOR NONSPLENECTOMIZED PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Rummel, J.
    Boccia, R.
    Macik, B. G.
    Pabinger, I.
    Selleslag, D.
    Gehl, L.
    Wang, X.
    Berger, D. P.
    Kuter, D. J.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 425 - 426
  • [34] Long-Term Use of the Thrombopoietin-Mimetic Romiplostim in Children With Severe Chronic Immune Thrombocytopenia (ITP)
    Bussel, James B.
    Hsieh, Loan
    Buchanan, George R.
    Stine, Kimo
    Kalpatthi, Ram
    Gnarra, David J.
    Ho, Richard H.
    Nie, Kun
    Eisen, Melissa
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 208 - 213
  • [35] A CASE OF REFRACTORY IMMUNE THROMBOCYTOPENIA (ITP) SUCCESSFULLY TREATED WITH ROMIPLOSTIM IN A PATIENT AFFECTED BY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Guidotti, F.
    Maura, F.
    Reda, G.
    Gregorini, A.
    Cortelezzi, A.
    [J]. HAEMATOLOGICA, 2012, 97 : 528 - 528
  • [36] Evolution of platelet function in adult patients with chronic immune thrombocytopenia on romiplostim treatment
    Ignatova, Anastasia A.
    Demina, Irina A.
    Ptushkin, Vadim V.
    Khaspekova, Svetlana G.
    Shustova, Olga N.
    Pankrashkina, Maria M.
    Ryabykh, Aleksandr A.
    Obydennyi, Sergei I.
    Strelkova, Olga S.
    Polokhov, Dmitry M.
    Seregina, Elena A.
    Poletaev, Aleksandr V.
    Ataullakhanov, Fazoil I.
    Kireev, Igor I.
    Mazurov, Alexei V.
    Maschan, Alexei A.
    Novichkova, Galina A.
    Panteleev, Mikhail A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) : E38 - E42
  • [37] Thrombopoietin Receptor Agonists Eltrombopag and romiplostim for the treatment of chronic immune thrombocytopenia purpura
    Atkinson, Katie
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2019, 23 (02) : 212 - 216
  • [38] Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside
    Molineux, Graham
    Newland, Adrian
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 9 - 20
  • [39] Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care
    Stasi, Roberto
    Murali, Magaral
    Michel, Marc
    Viallard, Jean-Francois
    Giagounidis, Aristoteles
    Janssens, Ann
    Legg, Jason
    Deuson, Robert
    Danese, Mark D.
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (01) : 26 - 33
  • [40] Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia
    Mokhtar, Galila M.
    Tantawy, Azza A. G.
    El Sherif, Nayera H. K.
    [J]. PLATELETS, 2012, 23 (04) : 264 - 273
12345